Roche’s COVID-19 Collaboration Strategy Sees Promise In Combinations
Infectious Disease Partnering Head Patrick Schleck Describes Priorities
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
